Drug Shortage Report for PRIORIX
| Report ID | 221711 |
| Drug Identification Number | 02239208 |
| Brand name | PRIORIX |
| Common or Proper name | Combined measles, mumps and rubella vaccine, live, attenuated |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | WATER RUBELLA VIRUS VACCINE LIVE ATTENUATED MEASLES VIRUS VACCINE LIVE ATTENUATED MUMPS VIRUS VACCINE LIVE ATTENUATED |
| Strength(s) | 0.5ML 1000CCID50 1000CCID50 10000CCID50 |
| Dosage form(s) | POWDER FOR SOLUTION KIT |
| Route of administration | SUBCUTANEOUS INTRAMUSCULAR INTRAMUSCULAR SUBCUTANEOUS |
| Packaging size | 10s |
| ATC code | J07BD |
| ATC description | VIRAL VACCINES |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2024-03-08 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-04-01 |
| Company comments | Supply available for public programs. Supply unavailable in the private market. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2024-04-01 | French | Compare |
| v4 | 2024-04-01 | English | Compare |
| v3 | 2024-03-09 | English | Compare |
| v2 | 2024-03-08 | French | Compare |
| v1 | 2024-03-08 | English | Compare |
Showing 1 to 5 of 5